Skip to Content

China SXT Pharmaceuticals Inc Ordinary Shares SXTC

Morningstar Rating
$1.05 +0.02 (1.94%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SXTC is trading at a 64% discount.
Price
$1.07
Fair Value
$2.50
Uncertainty
Extreme
1-Star Price
$47.95
5-Star Price
$1.23
Economic Moat
Rdlt
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SXTC is a good fit for your portfolio.

Trading Information

Previous Close Price
$1.03
Day Range
$1.031.10
52-Week Range
$0.949.38
Bid/Ask
$1.02 / $1.06
Market Cap
$593,809.65
Volume/Avg
203,439 / 1.2 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.29
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, Advanced TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates a majority of its revenue from the People's Republic of China.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
78

Valuation

Metric
SXTC
Price/Earnings (Normalized)
Price/Book Value
0.15
Price/Sales
0.29
Price/Cash Flow
Price/Earnings
SXTC

Financial Strength

Metric
SXTC
Quick Ratio
1.40
Current Ratio
1.47
Interest Coverage
−31.95
Quick Ratio
SXTC

Profitability

Metric
SXTC
Return on Assets (Normalized)
−62.69%
Return on Equity (Normalized)
−119.97%
Return on Invested Capital (Normalized)
−94.20%
Return on Assets
SXTC
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AWwhclzkhsjCfdxv$72.4 Bil
MKKGY
Merck KGaA ADRYwbltfknrqTxkvyp$70.8 Bil
HLN
Haleon PLC ADRSwlvvfbvGhvj$38.2 Bil
VTRS
Viatris IncDcvhcsxjRsrk$13.6 Bil
RDY
Dr Reddy's Laboratories Ltd ADRCkvndmngPnj$12.5 Bil
CTLT
Catalent IncMyhtlgkhTsldfrv$10.1 Bil
PRGO
Perrigo Co PLCMkrwkdslTrdjw$4.3 Bil
CURLF
Curaleaf Holdings IncQdjhmslKny$3.7 Bil
PBH
Prestige Consumer Healthcare IncJkrszmbtsQpljmc$3.5 Bil
GTBIF
Green Thumb Industries IncTnzvpbffScjy$2.9 Bil

Sponsor Center